kabutan

Kohjin Bio, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 7% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 10 yen, This Fiscal Year to Increase Dividend by 1 yen

Wed May 14, 2025 3:30 pm JST Earnings

177A Kohjin Bio Co.,Ltd. 【J-GAAP】

Earnings Report

Kohjin Bio Co.,Ltd. <177A> [TSE Growth] announced its financial results after the market closed on May 14th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 expanded 67.7% from the previous period to 1.06 billion yen, exceeding the previous forecast of 0.87 billion yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to grow by 6.6% to 1.13 billion yen. This will be the seventh consecutive term of revenue growth.

At the same time, the company increased the annual dividend for the previous term from 14 yen to 24 yen (compared to 14 yen in the prior term), and has decided to increase the dividend this fiscal year to 25 yen, an increase of 1 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit increased 36.6% from the same period last year, reaching 0.32 billion yen. The operating profit margin jumped from 18.4% in the same period last year to 24.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 4,770 596 635 384 92.4 14 May 15, 2024 J-GAAP
Mar, 2025 5,206 991 1,065 794 157.6 24 May 14, 2025 J-GAAP
YoY +9.1% +66.3% +67.7% +106.8% +70.5%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 4,852 857 876 629 123.1 14 May 15, 2024 J-GAAP
Mar, 2025 Results 5,206 991 1,065 794 157.6 24 May 14, 2025 J-GAAP
Revision Rate +7.3% +15.6% +21.6% +26.2% +28.1%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 2,507 379 416 277 55.7 0 Nov 14, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 14, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 4,770 596 635 384 92.4 14 May 15, 2024 J-GAAP
Mar, 2025 5,206 991 1,065 794 157.6 24 May 14, 2025 J-GAAP
Mar, 2026 Guidance 5,679 1,065 1,135 822 160.8 25 May 14, 2025 J-GAAP
YoY +9.1% +7.5% +6.6% +3.5% +2.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 1,226 226 238 177 42.6 18.4 May 15, 2024 J-GAAP
Apr - Jun, 2024 1,241 206 225 162 33.6 16.6 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 1,266 173 191 115 23.1 13.7 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 1,416 296 324 239 47.7 20.9 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 1,283 316 325 278 55.2 24.6 May 14, 2025 J-GAAP
YoY +4.6% +39.8% +36.6% +57.1% +29.5%

Related Articles